“Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results from the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s423. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/3090.